Jane Street Group, LLC Leap Therapeutics, Inc. Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.72 $49,635 - $123,232	-171,156 Reduced 94.48%	10,008 $3,000
Q4 2022 Feb 14, 2023	BUY	$0.42 - $9.18 $21,021 - $459,468	50,051 Added 38.17%	181,164 $81,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $9.3 $120,623 - $1.22 Million	131,113 New	131,113 $115,000
Q3 2020 Nov 17, 2020	SELL	$1.68 - $2.17 $17,870 - $23,082	-10,637 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.39 - $2.84 $14,785 - $30,209	10,637 New	10,637 $22,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $239M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.